Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Genetech Pharm is a key manufacturing and R&D subsidiary of the Uni-Bio Science Group. It operates high-standard GMP production facilities in Beijing, specializing in aseptic production lines for biologics and chemical drugs. The company recently achieved a major milestone with the NMPA approval of Bogutai (rhPTH 1-34) for osteoporosis in early 2024. It also manufactures marketed products such as Pinup (voriconazole) and Boshutai (acarbose), and is developing next-generation delivery systems for its endocrine portfolio in collaboration with Ypsomed.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Genetech Pharm.